Australia expands public access to cancer immunotherapy
ROMA (ITALPRESS) – Australia expands public access to immunotherapy against cancer. From September 1st the pembrolizumab will be available through the Pharmaceutical Benefits Scheme, the national system that supports the cost of medicines, for new oncological indications. The extension concerns […]
Australia expands public access to cancer immunotherapy Read More »






